James is experienced in financial markets focusing on healthcare both on the market side as a pharmaceutical equity research analyst and as an advisor as a healthcare investment banker. Prior to joining Jefferies, he spent over two years at JPMorgan as a healthcare investment banker and nearly four years at Goldman Sachs as a pharmaceuticals equity research analyst.

Key Subjects

Languages